Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stockley

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Applied Laboratory Medicine|July 1, 2026
ADLM Guidance Document on Incorporating Gender Diversity in Pathology and Laboratory MedicineTiffany A Thomas, Gabrielle N Winston-McPherson, Ina Amarillo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2021
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancerA S Fung, D M Graham, E X Chen, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
Current Oncology (Toronto, Ont.)|November 12, 2019
OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharingE R Malone, R R Saleh, C Yu, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinomaKyaw L Aung, Elaine McWhirter, Stephen Welch, et al.
Journal of Medical Genetics|July 26, 2018
Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmapJeanna M McCuaig, Tracy L Stockley, Patricia Shaw, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2025
Correction: Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction ModelNasim Mavaddat, Lorenzo Ficorella, Tim Carver, et al.
Eclinicalmedicine|February 21, 2024
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative dataAlberto Hernando-Calvo, Paul Nguyen, Philippe L Bedard, et al.
International Journal of Food Microbiology|March 25, 2018
A pan-European ring trial to validate an International Standard for detection of Vibrio cholerae, Vibrio parahaemolyticus and Vibrio vulnificus in seafoodsR E Hartnell, L Stockley, W Keay, et al.
JCO Precision Oncology|February 9, 2022
Minimally Invasive Real-Time Detection of Actionable Mutations in Patients With Metastatic Solid Tumors Using Fine-Needle and Liquid BiopsiesKyaw L Aung, Philippe L Bedard, Celeste Yu, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Applied Laboratory Medicine|July 1, 2026
ADLM Guidance Document on Incorporating Gender Diversity in Pathology and Laboratory MedicineTiffany A Thomas, Gabrielle N Winston-McPherson, Ina Amarillo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2021
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancerA S Fung, D M Graham, E X Chen, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
Current Oncology (Toronto, Ont.)|November 12, 2019
OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharingE R Malone, R R Saleh, C Yu, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinomaKyaw L Aung, Elaine McWhirter, Stephen Welch, et al.
Journal of Medical Genetics|July 26, 2018
Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmapJeanna M McCuaig, Tracy L Stockley, Patricia Shaw, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2025
Correction: Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction ModelNasim Mavaddat, Lorenzo Ficorella, Tim Carver, et al.
Eclinicalmedicine|February 21, 2024
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative dataAlberto Hernando-Calvo, Paul Nguyen, Philippe L Bedard, et al.
International Journal of Food Microbiology|March 25, 2018
A pan-European ring trial to validate an International Standard for detection of Vibrio cholerae, Vibrio parahaemolyticus and Vibrio vulnificus in seafoodsR E Hartnell, L Stockley, W Keay, et al.
JCO Precision Oncology|February 9, 2022
Minimally Invasive Real-Time Detection of Actionable Mutations in Patients With Metastatic Solid Tumors Using Fine-Needle and Liquid BiopsiesKyaw L Aung, Philippe L Bedard, Celeste Yu, et al.
Pageof 12